CDK9 and cancer: MiR-206 is downregulated during tumorigenesis and plays an important role in modulating the growth of multiple HCC cells via targeting cyclin-dependent kinase 9 (CDK9), which stimulates the production of abundant prosurvival proteins, leading to impaired cancer cell apoptosis [147].